Sue Friedman Provides an Overview of the ABOUT Network

Article

Sue Friedman, discusses the ABOUT Network, which is the first-ever patient-powered research registry created and governed by and for people affected by hereditary breast and ovarian cancers.

Sue Friedman, Executive Director, FORCE (Facing Our Risk of Cancer Empowered), discusses the ABOUT Network, which is the first-ever patient-powered research registry created and governed by and for people affected by hereditary breast and ovarian cancers.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
4 experts in this video
4 experts in this video
Image of a woman with blonde hair wearing a black shirt in front of a blue background
Photo of a man with a beard in front of a blue background
4 experts in this video
4 experts in this video
Related Content
graphic of a breast with a tumor

KN026/KN046 Combo Yields Durable Responses in HER2+ mBC

Jax DiEugenio
July 7th 2025
Article

KN026 plus KN046 produced sustained responses and showed a manageable safety profile in pretreated patients with HER2-positive advanced breast cancer.

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Lindsay Fischer
October 2nd 2023
Podcast

Ryan Tamargo, NP, AONCP, discusses the launch of an online inflammatory breast cancer scoring system tool.

Photo of a woman with brown hair and bangs, surrounded by a blue border

AE Education Aids Breast Cancer Decisions, Says Survivorship Expert

Michelle Kirschner, RN, MSN, ACNP, APRN-BC
June 30th 2025
Article

Planning for adverse effects early on helps patients prepare for what lies ahead, says Michelle Kirschner, MSN, RN, ACNP, APRN-BC.

The Vitals

Lauren Mahon Offers Nurse Perspectives on PARP Inhibitors As Ovarian Cancer Maintenance Therapy

Lindsay Fischer
June 15th 2023
Podcast

Lauren Mahon, MSN, FNP-BC, breaks down what oncology nurses should know about PARP inhibitors in ovarian cancer.

Graphic of an ovary

WRN Inhibitors May Address Immunotherapy Resistance in MSI+ Tumors

Amanda Brink, DNP, APRN, FNP-BC, AOCNP
June 24th 2025
Article

Oncology nurses can help patients understand this novel mechanism of action and its potential as a treatment option.

Image of icons representing different organs in a circle with the female reproductive system in the middle under a magnifying glass

Relacorilant Combo Sustains Ovarian Cancer Benefit Post Platinum Break

Chris Ryan
June 23rd 2025
Article

The combination of relacorilant and nab-paclitaxel improved survival in platinum-resistant ovarian cancer following a break from platinum-based chemo.